Stocks
Drugs Made In America Acquisition Corp.DMAA
NASDAQFinancial ServicesShell Companies$10.88
Price as of · delayed, not real-time
A blank-check company formed to acquire or merge with a business in the financial services sector. It has no operating assets and trades based on its ability to identify a target. Investors track it for potential merger announcements and arbitrage opportunities.
52W Range: $10.30-$10.89
Congressional Interest in Drugs Made In America Acquisition Corp. (DMAA)
No congressional trades have been disclosed for Drugs Made In America Acquisition Corp. (DMAA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DMAA?
No congressional trades found for this stock.